-
1
-
-
77955647582
-
Gut microbiota in health and disease
-
Sekirov, I.; Russell, S.L.; Antunes, L.C.; Finlay, B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90, 859–904
-
(2010)
Physiol. Rev
, vol.90
, pp. 859-904
-
-
Sekirov, I.1
Russell, S.L.2
Antunes, L.C.3
Finlay, B.B.4
-
2
-
-
77950251400
-
A human gut microbial gene catalogue established by metagenomic sequencing
-
Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65
-
(2010)
Nature
, vol.464
, pp. 59-65
-
-
Qin, J.1
Li, R.2
Raes, J.3
Arumugam, M.4
Burgdorf, K.S.5
Manichanh, C.6
Nielsen, T.7
Pons, N.8
Levenez, F.9
Yamada, T.10
-
3
-
-
32944466887
-
Ecological and evolutionary forces shaping microbial diversity in the human intestine
-
Ley, R.E.; Peterson, D.A.; Gordon, J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124, 837–848
-
(2006)
Cell
, vol.124
, pp. 837-848
-
-
Ley, R.E.1
Peterson, D.A.2
Gordon, J.I.3
-
4
-
-
84883084998
-
Microbiology: Wealth management in the gut
-
Fang, S.; Evans, R.M. Microbiology: Wealth management in the gut. Nature 2013, 500, 538–539
-
(2013)
Nature
, vol.500
, pp. 538-539
-
-
Fang, S.1
Evans, R.M.2
-
5
-
-
84891479561
-
The function of our microbiota: Who is out there and what do they do? Front
-
Ottman, N.; Smidt, H.; de Vos, W.M.; Belzer, C. The function of our microbiota: Who is out there and what do they do? Front. Cell. Infect. Microbiol. 2012, 2
-
(2012)
Cell. Infect. Microbiol
, vol.2
-
-
Ottman, N.1
Smidt, H.2
De Vos, W.M.3
Belzer, C.4
-
6
-
-
35348857386
-
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
-
Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780–13785
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 13780-13785
-
-
Frank, D.N.1
St Amand, A.L.2
Feldman, R.A.3
Boedeker, E.C.4
Harpaz, N.5
Pace, N.R.6
-
7
-
-
84898809123
-
The microbiome in inflammatory bowel disease: Current status and the future ahead
-
Kostic, A.D.; Xavier, R.J.; Gevers, D. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology 2014, 146, 1489–1499
-
(2014)
Gastroenterology
, vol.146
, pp. 1489-1499
-
-
Kostic, A.D.1
Xavier, R.J.2
Gevers, D.3
-
8
-
-
84867208167
-
The gut microbiota in IBD
-
Manichanh, C.; Borruel, N.; Casellas, F.; Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 599–608
-
(2012)
Nat. Rev. Gastroenterol. Hepatol
, vol.9
, pp. 599-608
-
-
Manichanh, C.1
Borruel, N.2
Casellas, F.3
Guarner, F.4
-
9
-
-
84858153337
-
Role of the microbiota in inflammatory bowel diseases
-
Nagalingam, N.A.; Lynch, S.V. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 2012, 18, 968–984
-
(2012)
Inflamm. Bowel Dis
, vol.18
, pp. 968-984
-
-
Nagalingam, N.A.1
Lynch, S.V.2
-
10
-
-
30944466824
-
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
-
Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; Gloux, K.; Pelletier, E.; Frangeul, L.; Nalin, R.; Jarrin, C.; Chardon, P.; Marteau, P. et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 2006, 55, 205–211
-
(2006)
Gut
, vol.55
, pp. 205-211
-
-
Manichanh, C.1
Rigottier-Gois, L.2
Bonnaud, E.3
Gloux, K.4
Pelletier, E.5
Frangeul, L.6
Nalin, R.7
Jarrin, C.8
Chardon, P.9
Marteau, P.10
-
11
-
-
38649115342
-
Microbial influences in inflammatory bowel diseases
-
Sartor, R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134, 577–594
-
(2008)
Gastroenterology
, vol.134
, pp. 577-594
-
-
Sartor, R.B.1
-
12
-
-
84871530893
-
Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis
-
Nemoto, H.; Kataoka, K.; Ishikawa, H.; Ikata, K.; Arimochi, H.; Iwasaki, T.; Ohnishi, Y.; Kuwahara, T.; Yasutomo, K. Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig. Dis. Sci. 2012, 57, 2955–2964
-
(2012)
Dig. Dis. Sci
, vol.57
, pp. 2955-2964
-
-
Nemoto, H.1
Kataoka, K.2
Ishikawa, H.3
Ikata, K.4
Arimochi, H.5
Iwasaki, T.6
Ohnishi, Y.7
Kuwahara, T.8
Yasutomo, K.9
-
13
-
-
61649087487
-
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis
-
Nishikawa, J.; Kudo, T.; Sakata, S.; Benno, Y.; Sugiyama, T. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand. J. Gastroenterol. 2009, 44, 180–186
-
(2009)
Scand. J. Gastroenterol.
, vol.44
, pp. 180-186
-
-
Nishikawa, J.1
Kudo, T.2
Sakata, S.3
Benno, Y.4
Sugiyama, T.5
-
14
-
-
2342442430
-
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
-
Ott, S.J.; Musfeldt, M.; Wenderoth, D.F.; Hampe, J.; Brant, O.; Folsch, U.R.; Timmis, K.N.; Schreiber, S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53, 685–693
-
(2004)
Gut
, vol.53
, pp. 685-693
-
-
Ott, S.J.1
Musfeldt, M.2
Wenderoth, D.F.3
Hampe, J.4
Brant, O.5
Folsch, U.R.6
Timmis, K.N.7
Schreiber, S.8
-
15
-
-
84873717548
-
The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease
-
Sha, S.; Xu, B.; Wang, X.; Zhang, Y.; Wang, H.; Kong, X.; Zhu, H.; Wu, K. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn. Microbiol. Infect. Dis. 2013, 75, 245–251
-
(2013)
Diagn. Microbiol. Infect. Dis
, vol.75
, pp. 245-251
-
-
Sha, S.1
Xu, B.2
Wang, X.3
Zhang, Y.4
Wang, H.5
Kong, X.6
Zhu, H.7
Wu, K.8
-
16
-
-
77949538579
-
Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency
-
Thibault, R.; Blachier, F.; Darcy-Vrillon, B.; De, C.P.; Bourreille, A.; Segain, J.P. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency. Inflamm. Bowel Dis. 2010, 16, 684–695
-
(2010)
Inflamm. Bowel Dis.
, vol.16
, pp. 684-695
-
-
Thibault, R.1
Blachier, F.2
Darcy-Vrillon, B.3
De, C.P.4
Bourreille, A.5
Segain, J.P.6
-
17
-
-
84925486076
-
The gut microbiota and inflammatory bowel disease
-
Matsuoka, K.; Kanai, T. The gut microbiota and inflammatory bowel disease. Semin. Immunopathol. 2015, 37, 47–55
-
(2015)
Semin. Immunopathol
, vol.37
, pp. 47-55
-
-
Matsuoka, K.1
Kanai, T.2
-
18
-
-
84862287933
-
Food and the gut microbiota in inflammatory bowel diseases: A critical connection
-
Albenberg, L.G.; Lewis, J.D.; Wu, G.D. Food and the gut microbiota in inflammatory bowel diseases: A critical connection. Curr. Opin. Gastroenterol. 2012, 28, 314–320
-
(2012)
Curr. Opin. Gastroenterol.
, vol.28
, pp. 314-320
-
-
Albenberg, L.G.1
Lewis, J.D.2
Wu, G.D.3
-
19
-
-
14544275997
-
Origins and evolution of the Western diet: Health implications for the 21st century
-
Cordain, L.; Eaton, S.B.; Sebastian, A.; Mann, N.; Lindeberg, S.; Watkins, B.A.; O’Keefe, J.H.; Brand-Miller, J. Origins and evolution of the Western diet: Health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81, 341–354
-
(2005)
Am. J. Clin. Nutr
, vol.81
, pp. 341-354
-
-
Cordain, L.1
Eaton, S.B.2
Sebastian, A.3
Mann, N.4
Lindeberg, S.5
Watkins, B.A.6
O’Keefe, J.H.7
Brand-Miller, J.8
-
20
-
-
79953773560
-
Dietary intake and risk of developing inflammatory bowel disease: A systematic review of the literature
-
Hou, J.K.; Abraham, B.; El-Serag, H. Dietary intake and risk of developing inflammatory bowel disease: A systematic review of the literature. Am. J. Gastroenterol. 2011, 106, 563–573
-
(2011)
Am. J. Gastroenterol
, vol.106
, pp. 563-573
-
-
Hou, J.K.1
Abraham, B.2
El-Serag, H.3
-
21
-
-
84928412757
-
Diet in the pathogenesis and treatment of inflammatory bowel diseases
-
Lee, D.; Albenberg, L.; Compher, C.; Baldassano, R.; Piccoli, D.; Lewis, J.D.; Wu, G.D. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 2015, 148, 1087–1106
-
(2015)
Gastroenterology
, vol.148
, pp. 1087-1106
-
-
Lee, D.1
Albenberg, L.2
Compher, C.3
Baldassano, R.4
Piccoli, D.5
Lewis, J.D.6
Wu, G.D.7
-
22
-
-
83755219473
-
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
-
Molodecky, N.A.; Soon, I.S.; Rabi, D.M.; Ghali, W.A.; Ferris, M.; Chernoff, G.; Benchimol, E.I.; Panaccione, R.; Ghosh, S.; Barkema, H.W. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142, 46–54
-
(2012)
Gastroenterology
, vol.142
, pp. 46-54
-
-
Molodecky, N.A.1
Soon, I.S.2
Rabi, D.M.3
Ghali, W.A.4
Ferris, M.5
Chernoff, G.6
Benchimol, E.I.7
Panaccione, R.8
Ghosh, S.9
Barkema, H.W.10
-
23
-
-
77957075815
-
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
-
De Filippo, C.; Cavalieri, D.; Di, P.M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691–14696
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 14691-14696
-
-
De Filippo, C.1
Cavalieri, D.2
Di, P.M.3
Ramazzotti, M.4
Poullet, J.B.5
Massart, S.6
Collini, S.7
Pieraccini, G.8
Lionetti, P.9
-
24
-
-
84862141704
-
Human gut microbiome viewed across age and geography
-
Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P. et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227
-
(2012)
Nature
, vol.486
, pp. 222-227
-
-
Yatsunenko, T.1
Rey, F.E.2
Manary, M.J.3
Trehan, I.4
Dominguez-Bello, M.G.5
Contreras, M.6
Magris, M.7
Hidalgo, G.8
Baldassano, R.N.9
Anokhin, A.P.10
-
25
-
-
84892828465
-
Diet rapidly and reproducibly alters the human gut microbiome
-
David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563
-
(2014)
Nature
, vol.505
, pp. 559-563
-
-
David, L.A.1
Maurice, C.F.2
Carmody, R.N.3
Gootenberg, D.B.4
Button, J.E.5
Wolfe, B.E.6
Ling, A.V.7
Devlin, A.S.8
Varma, Y.9
Fischbach, M.A.10
-
26
-
-
84863436944
-
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-{- mice
-
- mice. Nature 2012, 487, 104–108
-
(2012)
Nature
, vol.487
, pp. 104-108
-
-
Devkota, S.1
Wang, Y.2
Musch, M.W.3
Leone, V.4
Fehlner-Peach, H.5
Nadimpalli, A.6
Antonopoulos, D.A.7
Jabri, B.8
Chang, E.B.9
-
27
-
-
78751580602
-
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
-
Walker, A.W.; Ince, J.; Duncan, S.H.; Webster, L.M.; Holtrop, G.; Ze, X.; Brown, D.; Stares, M.D.; Scott, P.; Bergerat, A. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220–230
-
(2011)
ISME J
, vol.5
, pp. 220-230
-
-
Walker, A.W.1
Ince, J.2
Duncan, S.H.3
Webster, L.M.4
Holtrop, G.5
Ze, X.6
Brown, D.7
Stares, M.D.8
Scott, P.9
Bergerat, A.10
-
28
-
-
80053618114
-
Linking long-term dietary patterns with gut microbial enterotypes
-
Wu, G.D.; Chen, J.; Hoffmann, C.; Bittinger, K.; Chen, Y.Y.; Keilbaugh, S.A.; Bewtra, M.; Knights, D.; Walters, W.A.; Knight, R. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105–108
-
(2011)
Science
, vol.334
, pp. 105-108
-
-
Wu, G.D.1
Chen, J.2
Hoffmann, C.3
Bittinger, K.4
Chen, Y.Y.5
Keilbaugh, S.A.6
Bewtra, M.7
Knights, D.8
Walters, W.A.9
Knight, R.10
-
29
-
-
79952756960
-
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
-
Dethlefsen, L.; Relman, D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 2011, 108, 4554–4561
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 4554-4561
-
-
Dethlefsen, L.1
Relman, D.A.2
-
30
-
-
84885641936
-
Gut microbiota disturbance during antibiotic therapy: A multi-omic approach
-
Perez-Cobas, A.E.; Gosalbes, M.J.; Friedrichs, A.; Knecht, H.; Artacho, A.; Eismann, K.; Otto, W.; Rojo, D.; Bargiela, R.; von, B.M. et al. Gut microbiota disturbance during antibiotic therapy: A multi-omic approach. Gut 2013, 62, 1591–1601
-
(2013)
Gut
, vol.62
, pp. 1591-1601
-
-
Perez-Cobas, A.E.1
Gosalbes, M.J.2
Friedrichs, A.3
Knecht, H.4
Artacho, A.5
Eismann, K.6
Otto, W.7
Rojo, D.8
Bargiela, R.9
Von, B.M.10
-
31
-
-
84910057313
-
Host lifestyle affects human microbiota on daily timescales
-
David, L.A.; Materna, A.C.; Friedman, J.; Campos-Baptista, M.I.; Blackburn, M.C.; Perrotta, A.; Erdman, S.E.; Alm, E.J. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014, 15, R89
-
(2014)
Genome Biol
, vol.15
-
-
David, L.A.1
Materna, A.C.2
Friedman, J.3
Campos-Baptista, M.I.4
Blackburn, M.C.5
Perrotta, A.6
Erdman, S.E.7
Alm, E.J.8
-
32
-
-
0029033135
-
Mediterranean diet pyramid: A cultural model for healthy eating
-
Willett, W.C.; Sacks, F.; Trichopoulou, A.; Drescher, G.; Ferro-Luzzi, A.; Helsing, E.; Trichopoulos, D. Mediterranean diet pyramid: A cultural model for healthy eating. Am. J. Clin. Nutr. 1995, 61, 1402S–1406S
-
(1995)
Am. J. Clin. Nutr
, vol.61
, pp. 1402S-1406S
-
-
Willett, W.C.1
Sacks, F.2
Trichopoulou, A.3
Drescher, G.4
Ferro-Luzzi, A.5
Helsing, E.6
Trichopoulos, D.7
-
33
-
-
84901006573
-
Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn’s disease patients
-
Marlow, G.; Ellett, S.; Ferguson, I.R.; Zhu, S.; Karunasinghe, N.; Jesuthasan, A.C.; Han, D.Y.; Fraser, A.G.; Ferguson, L.R. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn’s disease patients. Hum. Genom. 2013, 7, 24
-
(2013)
Hum. Genom
, vol.7
-
-
Marlow, G.1
Ellett, S.2
Ferguson, I.R.3
Zhu, S.4
Karunasinghe, N.5
Jesuthasan, A.C.6
Han, D.Y.7
Fraser, A.G.8
Ferguson, L.R.9
-
34
-
-
84864644426
-
Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model
-
Sanchez-Fidalgo, S.; Sanchez, D.I.; Cardeno, A.; Alarcon, D.L.L. Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model. Eur. J. Nutr. 2012, 51, 497–506
-
(2012)
Eur. J. Nutr
, vol.51
, pp. 497-506
-
-
Sanchez-Fidalgo, S.1
Sanchez, D.I.2
Cardeno, A.3
Alarcon, D.L.L.4
-
35
-
-
84903214930
-
Wine consumption and intestinal redox homeostasis
-
Biasi, F.; Deiana, M.; Guina, T.; Gamba, P.; Leonarduzzi, G.; Poli, G. Wine consumption and intestinal redox homeostasis. Redox. Biol. 2014, 2, 795–802
-
(2014)
Redox. Biol
, vol.2
, pp. 795-802
-
-
Biasi, F.1
Deiana, M.2
Guina, T.3
Gamba, P.4
Leonarduzzi, G.5
Poli, G.6
-
36
-
-
84893778210
-
Enteral nutrition in Crohn’s disease: An underused therapy
-
Kansal, S.; Wagner, J.; Kirkwood, C.D.; Catto-Smith, A.G. Enteral nutrition in Crohn’s disease: An underused therapy. Gastroenterol. Res. Pract. 2013, 2013, 482108
-
(2013)
Gastroenterol. Res. Pract
, vol.2013
-
-
Kansal, S.1
Wagner, J.2
Kirkwood, C.D.3
Catto-Smith, A.G.4
-
37
-
-
33744778418
-
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: A randomized controlled open-label trial
-
Borrelli, O.; Cordischi, L.; Cirulli, M.; Paganelli, M.; Labalestra, V.; Uccini, S.; Russo, P.M.; Cucchiara, S. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: A randomized controlled open-label trial. Clin. Gastroenterol. Hepatol. 2006, 4, 744–753
-
(2006)
Clin. Gastroenterol. Hepatol.
, vol.4
, pp. 744-753
-
-
Borrelli, O.1
Cordischi, L.2
Cirulli, M.3
Paganelli, M.4
Labalestra, V.5
Uccini, S.6
Russo, P.M.7
Cucchiara, S.8
-
38
-
-
34548363947
-
Meta-analysis: Enteral nutrition in active Crohn’s disease in children
-
Dziechciarz, P.; Horvath, A.; Shamir, R.; Szajewska, H. Meta-analysis: Enteral nutrition in active Crohn’s disease in children. Aliment. Pharmacol. Ther. 2007, 26, 795–806
-
(2007)
Aliment. Pharmacol. Ther
, vol.26
, pp. 795-806
-
-
Dziechciarz, P.1
Horvath, A.2
Shamir, R.3
Szajewska, H.4
-
39
-
-
0033934166
-
Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children
-
Heuschkel, R.B.; Menache, C.C.; Megerian, J.T.; Baird, A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J. Pediatr. Gastroenterol. Nutr. 2000, 31, 8–15
-
(2000)
J. Pediatr. Gastroenterol. Nutr
, vol.31
, pp. 8-15
-
-
Heuschkel, R.B.1
Menache, C.C.2
Megerian, J.T.3
Baird, A.E.4
-
40
-
-
84899988047
-
Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s disease
-
Grover, Z.; Muir, R.; Lewindon, P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s disease. J. Gastroenterol. 2014, 49, 638–645
-
(2014)
J. Gastroenterol
, vol.49
, pp. 638-645
-
-
Grover, Z.1
Muir, R.2
Lewindon, P.3
-
41
-
-
33747586529
-
Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach
-
Day, A.S.; Whitten, K.E.; Lemberg, D.A.; Clarkson, C.; Vitug-Sales, M.; Jackson, R.; Bohane, T.D. Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach. J. Gastroenterol. Hepatol. 2006, 21, 1609–1614
-
(2006)
J. Gastroenterol. Hepatol.
, vol.21
, pp. 1609-1614
-
-
Day, A.S.1
Whitten, K.E.2
Lemberg, D.A.3
Clarkson, C.4
Vitug-Sales, M.5
Jackson, R.6
Bohane, T.D.7
-
42
-
-
79952451143
-
Deficiency in children with inflammatory bowel disease
-
Levin, A.D.; Wadhera, V.; Leach, S.T.; Woodhead, H.J.; Lemberg, D.A.; Mendoza-Cruz, A.C.; Day, A.S. Vitamin D deficiency in children with inflammatory bowel disease. Dig. Dis. Sci. 2011, 56, 830–836
-
(2011)
Dig. Dis. Sci
, vol.56
, pp. 830-836
-
-
Levin, A.D.1
Wadhera, V.2
Leach, S.T.3
Woodhead, H.J.4
Lemberg, D.A.5
Mendoza-Cruz, A.C.6
Day, A.S.7
Vitamin, D.8
-
43
-
-
77953325187
-
Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease
-
Whitten, K.E.; Leach, S.T.; Bohane, T.D.; Woodhead, H.J.; Day, A.S. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease. J. Gastroenterol. 2010, 45, 399–405
-
(2010)
J. Gastroenterol.
, vol.45
, pp. 399-405
-
-
Whitten, K.E.1
Leach, S.T.2
Bohane, T.D.3
Woodhead, H.J.4
Day, A.S.5
-
44
-
-
3242884801
-
Improvement in quality of life of children with acute Crohn’s disease does not parallel mucosal healing after treatment with exclusive enteral nutrition
-
Afzal, N.A.; van Der Zaag-Loonen, H.J.; Arnaud-Battandier, F.; Davies, S.; Murch, S.; Derkx, B.; Heuschkel, R.; Fell, J.M. Improvement in quality of life of children with acute Crohn’s disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment. Pharmacol. Ther. 2004, 20, 167–172
-
(2004)
Aliment. Pharmacol. Ther
, vol.20
, pp. 167-172
-
-
Afzal, N.A.1
Van Der Zaag-Loonen, H.J.2
Arnaud-Battandier, F.3
Davies, S.4
Murch, S.5
Derkx, B.6
Heuschkel, R.7
Fell, J.M.8
-
45
-
-
38149017695
-
Systematic review: Nutritional therapy in paediatric Crohn’s disease
-
Day, A.S.; Whitten, K.E.; Sidler, M.; Lemberg, D.A. Systematic review: Nutritional therapy in paediatric Crohn’s disease. Aliment. Pharmacol. Ther. 2008, 27, 293–307
-
(2008)
Aliment. Pharmacol. Ther
, vol.27
, pp. 293-307
-
-
Day, A.S.1
Whitten, K.E.2
Sidler, M.3
Lemberg, D.A.4
-
46
-
-
84879463973
-
Enteral nutrition to suppress postoperative Crohn’s disease recurrence: A five-year prospective cohort study
-
Yamamoto, T.; Shiraki, M.; Nakahigashi, M.; Umegae, S.; Matsumoto, K. Enteral nutrition to suppress postoperative Crohn’s disease recurrence: A five-year prospective cohort study. Int. J. Colorectal. Dis. 2013, 28, 335–340
-
(2013)
Int. J. Colorectal. Dis
, vol.28
, pp. 335-340
-
-
Yamamoto, T.1
Shiraki, M.2
Nakahigashi, M.3
Umegae, S.4
Matsumoto, K.5
-
47
-
-
33845404598
-
Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: A prospective, non-randomized, parallel, controlled study
-
Yamamoto, T.; Nakahigashi, M.; Umegae, S.; Kitagawa, T.; Matsumoto, K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: A prospective, non-randomized, parallel, controlled study. Aliment. Pharmacol. Ther. 2007, 25, 67–72
-
(2007)
Aliment. Pharmacol. Ther
, vol.25
, pp. 67-72
-
-
Yamamoto, T.1
Nakahigashi, M.2
Umegae, S.3
Kitagawa, T.4
Matsumoto, K.5
-
48
-
-
84888104362
-
Use of exclusive enteral nutrition in adults with Crohn’s disease: A review. World
-
Wall, C.L.; Day, A.S.; Gearry, R.B. Use of exclusive enteral nutrition in adults with Crohn’s disease: A review. World J. Gastroenterol. 2013, 19, 7652–7660
-
(2013)
J. Gastroenterol
, vol.19
, pp. 7652-7660
-
-
Wall, C.L.1
Day, A.S.2
Gearry, R.B.3
-
50
-
-
27744573894
-
Enteral nutrition and microflora in pediatric Crohn’s disease
-
Lionetti, P.; Callegari, M.L.; Ferrari, S.; Cavicchi, M.C.; Pozzi, E.; de, M.M.; Morelli, L. Enteral nutrition and microflora in pediatric Crohn’s disease. JPEN J. Parenter. Enteral Nutr. 2005, 29, S173–S175
-
JPEN J. Parenter. Enteral Nutr.
, vol.2005
, Issue.29
, pp. S173-S175
-
-
Lionetti, P.1
Callegari, M.L.2
Ferrari, S.3
Cavicchi, M.C.4
Pozzi, E.5
De, M.M.6
Morelli, L.7
-
51
-
-
84869992194
-
Effect of exclusive enteral nutrition on gut microflora function in children with Crohn’s disease
-
Tjellstrom, B.; Hogberg, L.; Stenhammar, L.; Magnusson, K.E.; Midtvedt, T.; Norin, E.; Sundqvist, T. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn’s disease. Scand. J. Gastroenterol. 2012, 47, 1454–1459
-
(2012)
Scand. J. Gastroenterol
, vol.47
, pp. 1454-1459
-
-
Tjellstrom, B.1
Hogberg, L.2
Stenhammar, L.3
Magnusson, K.E.4
Midtvedt, T.5
Norin, E.6
Sundqvist, T.7
-
52
-
-
84902179457
-
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn’s disease during enteral nutrition. Inflamm
-
Gerasimidis, K.; Bertz, M.; Hanske, L.; Junick, J.; Biskou, O.; Aguilera, M.; Garrick, V.; Russell, R.K.; Blaut, M.; McGrogan, P. et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn’s disease during enteral nutrition. Inflamm. Bowel Dis. 2014, 20, 861–871
-
(2014)
Bowel Dis
, vol.20
, pp. 861-871
-
-
Gerasimidis, K.1
Bertz, M.2
Hanske, L.3
Junick, J.4
Biskou, O.5
Aguilera, M.6
Garrick, V.7
Russell, R.K.8
Blaut, M.9
McGrogan, P.10
-
53
-
-
84907300008
-
Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease
-
Palm, N.W.; de Zoete, M.R.; Cullen, T.W.; Barry, N.A.; Stefanowski, J.; Hao, L.; Degnan, P.H.; Hu, J.; Peter, I.; Zhang, W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014, 158, 1000–1010
-
(2014)
Cell
, vol.158
, pp. 1000-1010
-
-
Palm, N.W.1
De Zoete, M.R.2
Cullen, T.W.3
Barry, N.A.4
Stefanowski, J.5
Hao, L.6
Degnan, P.H.7
Hu, J.8
Peter, I.9
Zhang, W.10
-
54
-
-
84927642638
-
Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn’s disease
-
Kaakoush, N.O.; Day, A.S.; Leach, S.T.; Lemberg, D.A.; Nielsen, S.; Mitchell, H.M. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn’s disease. Clin. Transl. Gastroenterol. 2015, 6, e71
-
(2015)
Clin. Transl. Gastroenterol
, vol.6
-
-
Kaakoush, N.O.1
Day, A.S.2
Leach, S.T.3
Lemberg, D.A.4
Nielsen, S.5
Mitchell, H.M.6
-
55
-
-
79958271259
-
Existing dietary guidelines for Crohn’s disease and ulcerative colitis
-
Brown, A.C.; Rampertab, S.D.; Mullin, G.E. Existing dietary guidelines for Crohn’s disease and ulcerative colitis. Expert Rev. Gastroenterol. Hepatol. 2011, 5, 411–425
-
(2011)
Expert Rev. Gastroenterol. Hepatol.
, vol.5
, pp. 411-425
-
-
Brown, A.C.1
Rampertab, S.D.2
Mullin, G.E.3
-
56
-
-
77953259387
-
Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet
-
Chiba, M.; Abe, T.; Tsuda, H.; Sugawara, T.; Tsuda, S.; Tozawa, H.; Fujiwara, K.; Imai, H. Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet. World J. Gastroenterol. 2010, 16, 2484–2495
-
(2010)
World J. Gastroenterol
, vol.16
, pp. 2484-2495
-
-
Chiba, M.1
Abe, T.2
Tsuda, H.3
Sugawara, T.4
Tsuda, S.5
Tozawa, H.6
Fujiwara, K.7
Imai, H.8
-
57
-
-
84989996011
-
The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases
-
Haas, S.V.; Haas, M.P. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Am. J. Gastroenterol. 1955, 23, 344–360
-
(1955)
Am. J. Gastroenterol
, vol.23
, pp. 344-360
-
-
Haas, S.V.1
Haas, M.P.2
-
59
-
-
84893697959
-
Nutritional therapy in pediatric Crohn disease: The specific carbohydrate diet
-
Suskind, D.L.; Wahbeh, G.; Gregory, N.; Vendettuoli, H.; Christie, D. Nutritional therapy in pediatric Crohn disease: The specific carbohydrate diet. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 87–91
-
(2014)
J. Pediatr. Gastroenterol. Nutr
, vol.58
, pp. 87-91
-
-
Suskind, D.L.1
Wahbeh, G.2
Gregory, N.3
Vendettuoli, H.4
Christie, D.5
-
60
-
-
84917691544
-
Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease
-
Cohen, S.A.; Gold, B.D.; Oliva, S.; Lewis, J.; Stallworth, A.; Koch, B.; Eshee, L.; Mason, D. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 516–521
-
(2014)
J. Pediatr. Gastroenterol. Nutr
, vol.59
, pp. 516-521
-
-
Cohen, S.A.1
Gold, B.D.2
Oliva, S.3
Lewis, J.4
Stallworth, A.5
Koch, B.6
Eshee, L.7
Mason, D.8
-
61
-
-
21044435580
-
Personal view: Food for thought—Western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis
-
Gibson, P.R.; Shepherd, S.J. Personal view: Food for thought—Western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment. Pharmacol. Ther. 2005, 21, 1399–1409
-
(2005)
Aliment. Pharmacol. Ther
, vol.21
, pp. 1399-1409
-
-
Gibson, P.R.1
Shepherd, S.J.2
-
62
-
-
38049076430
-
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon
-
Croagh, C.; Shepherd, S.J.; Berryman, M.; Muir, J.G.; Gibson, P.R. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm. Bowel. Dis. 2007, 13, 1522–1528
-
(2007)
Inflamm. Bowel. Dis
, vol.13
, pp. 1522-1528
-
-
Croagh, C.1
Shepherd, S.J.2
Berryman, M.3
Muir, J.G.4
Gibson, P.R.5
-
63
-
-
58849136151
-
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—A pilot study
-
Gearry, R.B.; Irving, P.M.; Barrett, J.S.; Nathan, D.M.; Shepherd, S.J.; Gibson, P.R. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—A pilot study. J. Crohns Colitis 2009, 3, 8–14
-
(2009)
J. Crohns Colitis
, vol.3
, pp. 8-14
-
-
Gearry, R.B.1
Irving, P.M.2
Barrett, J.S.3
Nathan, D.M.4
Shepherd, S.J.5
Gibson, P.R.6
-
64
-
-
84908087121
-
Diet and inflammatory bowel disease: Review of patient-targeted recommendations
-
Hou, J.K.; Lee, D.; Lewis, J. Diet and inflammatory bowel disease: Review of patient-targeted recommendations. Clin. Gastroenterol. Hepatol. 2014, 12, 1592–1600
-
(2014)
Clin. Gastroenterol. Hepatol
, vol.12
, pp. 1592-1600
-
-
Hou, J.K.1
Lee, D.2
Lewis, J.3
-
65
-
-
84893695347
-
An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report
-
Olendzki, B.C.; Silverstein, T.D.; Persuitte, G.M.; Ma, Y.; Baldwin, K.R.; Cave, D. An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report. Nutr. J. 2014, 13
-
(2014)
Nutr. J
, vol.13
-
-
Olendzki, B.C.1
Silverstein, T.D.2
Persuitte, G.M.3
Ma, Y.4
Baldwin, K.R.5
Cave, D.6
-
66
-
-
80051774391
-
Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease
-
Rajendran, N.; Kumar, D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: A pilot study. Colorectal Dis. 2011, 13, 1009–1013
-
(2011)
A Pilot Study. Colorectal Dis.
, vol.13
, pp. 1009-1013
-
-
Rajendran, N.1
Kumar, D.2
-
67
-
-
75549088940
-
Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: A double-blind cross-over diet intervention study
-
Bentz, S.; Hausmann, M.; Piberger, H.; Kellermeier, S.; Paul, S.; Held, L.; Falk, W.; Obermeier, F.; Fried, M.; Scholmerich, J. et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: A double-blind cross-over diet intervention study. Digestion 2010, 81, 252–264
-
(2010)
Digestion
, vol.81
, pp. 252-264
-
-
Bentz, S.1
Hausmann, M.2
Piberger, H.3
Kellermeier, S.4
Paul, S.5
Held, L.6
Falk, W.7
Obermeier, F.8
Fried, M.9
Scholmerich, J.10
-
68
-
-
84877581248
-
Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders
-
Yao, C.K.; Gibson, P.R.; Shepherd, S.J. Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am. J. Gastroenterol. 2013, 108, 748–758
-
(2013)
Am. J. Gastroenterol
, vol.108
, pp. 748-758
-
-
Yao, C.K.1
Gibson, P.R.2
Shepherd, S.J.3
-
69
-
-
0035150737
-
Probiotics, prebiotics, and synbiotics—Approaching a definition
-
Schrezenmeir, J.; De, V.M. Probiotics, prebiotics, and synbiotics—Approaching a definition. Am. J. Clin. Nutr. 2001, 73, 361S–364S
-
(2001)
Am. J. Clin. Nutr
, vol.73
, pp. 361S-364S
-
-
Schrezenmeir, J.1
De, V.M.2
-
70
-
-
84905675648
-
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
-
Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514
-
(2014)
Nat. Rev. Gastroenterol. Hepatol
, vol.11
, pp. 506-514
-
-
Hill, C.1
Guarner, F.2
Reid, G.3
Gibson, G.R.4
Merenstein, D.J.5
Pot, B.6
Morelli, L.7
Canani, R.B.8
Flint, H.J.9
Salminen, S.10
-
71
-
-
77955944234
-
What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease
-
Cary, V.A.; Boullata, J. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? J. Clin. Nurs. 2010, 19, 904–916
-
(2010)
J. Clin. Nurs
, vol.19
, pp. 904-916
-
-
Cary, V.A.1
Boullata, J.2
-
72
-
-
54049093308
-
Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents
-
Henker, J.; Muller, S.; Laass, M.W.; Schreiner, A.; Schulze, J. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: An open-label pilot study. Z. Gastroenterol. 2008, 46, 874–875
-
(2008)
An Open-Label Pilot Study. Z. Gastroenterol.
, vol.46
, pp. 874-875
-
-
Henker, J.1
Muller, S.2
Laass, M.W.3
Schreiner, A.4
Schulze, J.5
-
73
-
-
0030611915
-
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
-
Kruis, W.; Schutz, E.; Fric, P.; Fixa, B.; Judmaier, G.; Stolte, M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 1997, 11, 853–858
-
(1997)
Aliment. Pharmacol. Ther
, vol.11
, pp. 853-858
-
-
Kruis, W.1
Schutz, E.2
Fric, P.3
Fixa, B.4
Judmaier, G.5
Stolte, M.6
-
74
-
-
33646560334
-
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
-
Zocco, M.A.; dal Verme, L.Z.; Cremonini, F.; Piscaglia, A.C.; Nista, E.C.; Candelli, M.; Novi, M.; Rigante, D.; Cazzato, I.A.; Ojetti, V. et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 2006, 23, 1567–1574
-
(2006)
Aliment. Pharmacol. Ther
, vol.23
, pp. 1567-1574
-
-
Zocco, M.A.1
Dal Verme, L.Z.2
Cremonini, F.3
Piscaglia, A.C.4
Nista, E.C.5
Candelli, M.6
Novi, M.7
Rigante, D.8
Cazzato, I.A.9
Ojetti, V.10
-
75
-
-
25444512029
-
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease
-
Bousvaros, A.; Guandalini, S.; Baldassano, R.N.; Botelho, C.; Evans, J.; Ferry, G.D.; Goldin, B.; Hartigan, L.; Kugathasan, S.; Levy, J. et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm. Bowel Dis. 2005, 11, 833–839
-
(2005)
Inflamm. Bowel Dis
, vol.11
, pp. 833-839
-
-
Bousvaros, A.1
Guandalini, S.2
Baldassano, R.N.3
Botelho, C.4
Evans, J.5
Ferry, G.D.6
Goldin, B.7
Hartigan, L.8
Kugathasan, S.9
Levy, J.10
-
76
-
-
2442717706
-
Lactobacillus GG in inducing and maintaining remission of Crohn’s disease
-
Schultz, M.; Timmer, A.; Herfarth, H.H.; Sartor, R.B.; Vanderhoof, J.A.; Rath, H.C. Lactobacillus GG in inducing and maintaining remission of Crohn’s disease. BMC Gastroenterol. 2004, 4, 5
-
(2004)
BMC Gastroenterol
, vol.4
-
-
Schultz, M.1
Timmer, A.2
Herfarth, H.H.3
Sartor, R.B.4
Vanderhoof, J.A.5
Rath, H.C.6
-
77
-
-
84855355717
-
Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol
-
Oliva, S.; Di, N.G.; Ferrari, F.; Mallardo, S.; Rossi, P.; Patrizi, G.; Cucchiara, S.; Stronati, L. Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol. Ther. 2012, 35, 327–334
-
(2012)
Ther
, vol.35
, pp. 327-334
-
-
Oliva, S.1
Di, N.G.2
Ferrari, F.3
Mallardo, S.4
Rossi, P.5
Patrizi, G.6
Cucchiara, S.7
Stronati, L.8
-
78
-
-
10644296437
-
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
-
Kato, K.; Mizuno, S.; Umesaki, Y.; Ishii, Y.; Sugitani, M.; Imaoka, A.; Otsuka, M.; Hasunuma, O.; Kurihara, R.; Iwasaki, A. et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 2004, 20, 1133–1141
-
(2004)
Aliment. Pharmacol. Ther
, vol.20
, pp. 1133-1141
-
-
Kato, K.1
Mizuno, S.2
Umesaki, Y.3
Ishii, Y.4
Sugitani, M.5
Imaoka, A.6
Otsuka, M.7
Hasunuma, O.8
Kurihara, R.9
Iwasaki, A.10
-
79
-
-
77951730354
-
Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis
-
Guslandi, M. Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis. J. Clin. Gastroenterol. 2010, 44
-
(2010)
J. Clin. Gastroenterol
, vol.44
-
-
Guslandi, M.1
-
80
-
-
0032815979
-
Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
-
Venturi, A.; Gionchetti, P.; Rizzello, F.; Johansson, R.; Zucconi, E.; Brigidi, P.; Matteuzzi, D.; Campieri, M. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 1999, 13, 1103–1108
-
(1999)
Aliment. Pharmacol. Ther
, vol.13
, pp. 1103-1108
-
-
Venturi, A.1
Gionchetti, P.2
Rizzello, F.3
Johansson, R.4
Zucconi, E.5
Brigidi, P.6
Matteuzzi, D.7
Campieri, M.8
-
81
-
-
72049119604
-
The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol
-
Sood, A.; Midha, V.; Makharia, G.K.; Ahuja, V.; Singal, D.; Goswami, P.; Tandon, R.K. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. Hepatol. 2009, 7, 1202–1209
-
(2009)
Hepatol
, vol.7
, pp. 1202-1209
-
-
Sood, A.1
Midha, V.2
Makharia, G.K.3
Ahuja, V.4
Singal, D.5
Goswami, P.6
Tandon, R.K.7
-
82
-
-
77957831387
-
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study
-
Tursi, A.; Brandimarte, G.; Papa, A.; Giglio, A.; Elisei, W.; Giorgetti, G.M.; Forti, G.; Morini, S.; Hassan, C.; Pistoia, M.A. et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 2010, 105, 2218–2227
-
(2010)
Am. J. Gastroenterol
, vol.105
, pp. 2218-2227
-
-
Tursi, A.1
Brandimarte, G.2
Papa, A.3
Giglio, A.4
Elisei, W.5
Giorgetti, G.M.6
Forti, G.7
Morini, S.8
Hassan, C.9
Pistoia, M.A.10
-
83
-
-
84906283953
-
Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis
-
Mardini, H.E.; Grigorian, A.Y. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: A meta-analysis. Inflamm. Bowel Dis. 2014, 20, 1562–1567
-
(2014)
A Meta-Analysis. Inflamm. Bowel Dis.
, vol.20
, pp. 1562-1567
-
-
Mardini, H.E.1
Grigorian, A.Y.2
-
84
-
-
0038185270
-
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
-
Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K.M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campieri, M. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 2003, 124, 1202–1209
-
(2003)
Gastroenterology
, vol.124
, pp. 1202-1209
-
-
Gionchetti, P.1
Rizzello, F.2
Helwig, U.3
Venturi, A.4
Lammers, K.M.5
Brigidi, P.6
Vitali, B.7
Poggioli, G.8
Miglioli, M.9
Campieri, M.10
-
85
-
-
84893687483
-
Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: Meta-analysis of randomized controlled trials
-
Shen, J.; Zuo, Z.X.; Mao, A.P. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: Meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 2014, 20, 21–35
-
(2014)
Inflamm. Bowel Dis.
, vol.20
, pp. 21-35
-
-
Shen, J.1
Zuo, Z.X.2
Mao, A.P.3
-
86
-
-
38749149901
-
European evidence-based Consensus on the management of ulcerative colitis: Special situations
-
Biancone, L.; Michetti, P.; Travis, S.; Escher, J.C.; Moser, G.; Forbes, A.; Hoffmann, J.C.; Dignass, A.; Gionchetti, P.; Jantschek, G. et al. European evidence-based Consensus on the management of ulcerative colitis: Special situations. J. Crohns Colitis 2008, 2, 63–92
-
(2008)
J. Crohns Colitis
, vol.2
, pp. 63-92
-
-
Biancone, L.1
Michetti, P.2
Travis, S.3
Escher, J.C.4
Moser, G.5
Forbes, A.6
Hoffmann, J.C.7
Dignass, A.8
Gionchetti, P.9
Jantschek, G.10
-
87
-
-
33744933432
-
Trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease
-
Braat, H.; Rottiers, P.; Hommes, D.W.; Huyghebaert, N.; Remaut, E.; Remon, J.P.; van Deventer, S.J.; Neirynck, S.; Peppelenbosch, M.P.; Steidler, L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroenterol. Hepatol. 2006, 4, 754–759
-
(2006)
Clin. Gastroenterol. Hepatol
, vol.4
, pp. 754-759
-
-
Braat, H.1
Rottiers, P.2
Hommes, D.W.3
Huyghebaert, N.4
Remaut, E.5
Remon, J.P.6
Van Deventer, S.J.7
Neirynck, S.8
Peppelenbosch, M.P.9
Steidler, L.A.10
Phase, I.11
-
88
-
-
84929646195
-
Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models
-
De Moreno de LeBlanc, A.; del Carmen, S.; Chatel, J.M.; Miyoshi, A.; Azevedo, V.; Langella, P.; Bermdez-Humarín, L.G.; LeBlanc, J.G. Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models. Gastroenterol. Res. Pract. 2015, 2015, 146972
-
(2015)
Gastroenterol. Res. Pract
, vol.2015
-
-
De Moreno De Leblanc, A.1
Del Carmen, S.2
Chatel, J.M.3
Miyoshi, A.4
Azevedo, V.5
Langella, P.6
Bermdez-Humarín, L.G.7
Leblanc, J.G.8
-
89
-
-
84892957370
-
Genetically Engineered Immunomodulatory Streptococcus thermophilus Strains Producing Antioxidant Enzymes Exhibit Enhanced Anti-Inflammatory Activities
-
Del Carmen, S.; de Moreno de LeBlanc, A.; Martin, R.; Chain, F.; Langella, P.; Bermdez-Humaín, L.G.; LeBlanc, J.G. Genetically Engineered Immunomodulatory Streptococcus thermophilus Strains Producing Antioxidant Enzymes Exhibit Enhanced Anti-Inflammatory Activities. Appl. Environm. Microbiol. 2014, 80, 869–877
-
(2014)
Appl. Environm. Microbiol
, vol.80
, pp. 869-877
-
-
Del Carmen, S.1
De Moreno De Leblanc, A.2
Martin, R.3
Chain, F.4
Langella, P.5
Bermdez-Humaín, L.G.6
Leblanc, J.G.7
-
90
-
-
79151475419
-
Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn’s disease in mice
-
LeBlanc, J.G.; del Carmen, S.; Miyoshi, A.; Azevedo, V.; Sesma, F.; Langella, P.; Bermdez-Humarín, L.G.; Watterlot, L.; Perdigon, G.; de Moreno de LeBlanc, A. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn’s disease in mice. J. Biotechnol. 2011, 151, 287–293
-
(2011)
J. Biotechnol
, vol.151
, pp. 287-293
-
-
Leblanc, J.G.1
Del Carmen, S.2
Miyoshi, A.3
Azevedo, V.4
Sesma, F.5
Langella, P.6
Bermdez-Humarín, L.G.7
Watterlot, L.8
Perdigon, G.9
De Moreno De Leblanc, A.10
-
91
-
-
80054098741
-
Recommendations for probiotic use-2011 update
-
Floch, M.H.; Walker, W.A.; Madsen, K.; Sanders, M.E.; Macfarlane, G.T.; Flint, H.J.; Dieleman, L.A.; Ringel, Y.; Guandalini, S.; Kelly, C.P. et al. Recommendations for probiotic use-2011 update. J. Clin. Gastroenterol. 2011, 45, S168–S171
-
(2011)
J. Clin. Gastroenterol
, vol.45
, pp. S168-S171
-
-
Floch, M.H.1
Walker, W.A.2
Madsen, K.3
Sanders, M.E.4
Macfarlane, G.T.5
Flint, H.J.6
Dieleman, L.A.7
Ringel, Y.8
Guandalini, S.9
Kelly, C.P.10
-
92
-
-
84869089859
-
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: Current management
-
Dignass, A.; Lindsay, J.O.; Sturm, A.; Windsor, A.; Colombel, J.F.; Allez, M.; d’Haens, G.; d’Hoore, A.; Mantzaris, G.; Novacek, G. et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: Current management. J. Crohns Colitis 2012, 6, 991–1030
-
(2012)
J. Crohns Colitis
, vol.6
, pp. 991-1030
-
-
Dignass, A.1
Lindsay, J.O.2
Sturm, A.3
Windsor, A.4
Colombel, J.F.5
Allez, M.6
D’Haens, G.7
D’Hoore, A.8
Mantzaris, G.9
Novacek, G.10
-
93
-
-
80054108815
-
Probiotics in the treatment of human inflammatory bowel diseases: Update 2011
-
Meijer, B.J.; Dieleman, L.A. Probiotics in the treatment of human inflammatory bowel diseases: Update 2011. J. Clin. Gastroenterol. 2011, 45, S139–S144
-
(2011)
J. Clin. Gastroenterol
, vol.45
, pp. S139-S144
-
-
Meijer, B.J.1
Dieleman, L.A.2
-
94
-
-
33947136322
-
Prebiotics: The concept revisited
-
Roberfroid, M. Prebiotics: The concept revisited. J. Nutr. 2007, 137, 830S–837S
-
(2007)
J. Nutr
, vol.137
, pp. 830S-837S
-
-
Roberfroid, M.1
-
95
-
-
40549117236
-
Probiotics and prebiotics in inflammatory bowel disease: Microflora “on the scope”
-
Damaskos, D.; Kolios, G. Probiotics and prebiotics in inflammatory bowel disease: Microflora “on the scope”. Br. J. Clin. Pharmacol. 2008, 65, 453–467
-
(2008)
Br. J. Clin. Pharmacol
, vol.65
, pp. 453-467
-
-
Damaskos, D.1
Kolios, G.2
-
96
-
-
14744305964
-
The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease
-
Kanauchi, O.; Matsumoto, Y.; Matsumura, M.; Fukuoka, M.; Bamba, T. The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. Curr. Pharm. Des. 2005, 11, 1047–1053
-
(2005)
Curr. Pharm. Des
, vol.11
, pp. 1047-1053
-
-
Kanauchi, O.1
Matsumoto, Y.2
Matsumura, M.3
Fukuoka, M.4
Bamba, T.5
-
97
-
-
2442470586
-
Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial
-
Kanauchi, O.; Mitsuyama, K.; Homma, T.; Takahama, K.; Fujiyama, Y.; Andoh, A.; Araki, Y.; Suga, T.; Hibi, T.; Naganuma, M. et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial. Int. J. Mol. Med. 2003, 12, 701–704
-
(2003)
Int. J. Mol. Med
, vol.12
, pp. 701-704
-
-
Kanauchi, O.1
Mitsuyama, K.2
Homma, T.3
Takahama, K.4
Fujiyama, Y.5
Andoh, A.6
Araki, Y.7
Suga, T.8
Hibi, T.9
Naganuma, M.10
-
98
-
-
16644381082
-
Germinated barley foodstuff prolongs remission in patients with ulcerative colitis
-
Hanai, H.; Kanauchi, O.; Mitsuyama, K.; Andoh, A.; Takeuchi, K.; Takayuki, I.; Araki, Y.; Fujiyama, Y.; Toyonaga, A.; Sata, M. et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int. J. Mol. Med. 2004, 13, 643–647
-
(2004)
Int. J. Mol. Med
, vol.13
, pp. 643-647
-
-
Hanai, H.1
Kanauchi, O.2
Mitsuyama, K.3
Andoh, A.4
Takeuchi, K.5
Takayuki, I.6
Araki, Y.7
Fujiyama, Y.8
Toyonaga, A.9
Sata, M.10
-
99
-
-
79956099446
-
Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-
-
Faghfoori, Z.; Navai, L.; Shakerhosseini, R.; Somi, M.H.; Nikniaz, Z.; Norouzi, M.F. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-a, interleukin-6 and -8 in patients with ulcerative colitis. Ann. Clin. Biochem. 2011, 48, 233–237.
-
(2011)
Ann. Clin. Biochem.
, vol.48
, pp. 233-237
-
-
Faghfoori, Z.1
Navai, L.2
Shakerhosseini, R.3
Somi, M.H.4
Nikniaz, Z.5
Norouzi, M.F.6
-
100
-
-
84943406180
-
Abadi, A. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis
-
Faghfoori, Z.; Shakerhosseini, R.; Navai, L.; Somi, M.H.; Nikniaz, Z.; Abadi, A. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promot. Perspect. 2014, 4, 116–121.
-
(2014)
Health Promot. Perspect
, vol.4
, pp. 116-121
-
-
Faghfoori, Z.1
Shakerhosseini, R.2
Navai, L.3
Somi, M.H.4
Nikniaz, Z.5
-
101
-
-
33144470875
-
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease
-
Lindsay, J.O.; Whelan, K.; Stagg, A.J.; Gobin, P.; Al-Hassi, H.O.; Rayment, N.; Kamm, M.A.; Knight, S.C.; Forbes, A. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 2006, 55, 348–355.
-
(2006)
Gut
, vol.55
, pp. 348-355
-
-
Lindsay, J.O.1
Whelan, K.2
Stagg, A.J.3
Gobin, P.4
Al-Hassi, H.O.5
Rayment, N.6
Kamm, M.A.7
Knight, S.C.8
Forbes, A.9
-
102
-
-
79958221480
-
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s disease
-
Benjamin, J.L.; Hedin, C.R.H.; Koutsoumpas, A.; Ng, S.C.; McCarthy, N.E.; Hart, A.L.; Kamm, M.A.; Sanderson, J.D.; Knight, S.C.; Forbes, A. et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s disease. Gut 2011, 60, 923–929.
-
(2011)
Gut
, vol.60
, pp. 923-929
-
-
Benjamin, J.L.1
Hedin, C.R.H.2
Koutsoumpas, A.3
Ng, S.C.4
McCarthy, N.E.5
Hart, A.L.6
Kamm, M.A.7
Sanderson, J.D.8
Knight, S.C.9
Forbes, A.10
-
103
-
-
34247096518
-
Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment. Pharmacol
-
Casellas, F.; Borruel, N.; Torrejon, A.; Varela, E.; Antolin, M.; Guarner, F.; Malagelada, J.R. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment. Pharmacol. Ther. 2007, 25, 1061–1067.
-
(2007)
Ther
, vol.25
, pp. 1061-1067
-
-
Casellas, F.1
Borruel, N.2
Torrejon, A.3
Varela, E.4
Antolin, M.5
Guarner, F.6
Malagelada, J.R.7
-
104
-
-
0036255497
-
Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis
-
Welters, C.F.; Heineman, E.; Thunnissen, F.B.; van den Bogaard, A.E.; Soeters, P.B.; Baeten, C.G. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis. Colon Rectum. 2002, 45, 621–627.
-
(2002)
Dis. Colon Rectum
, vol.45
, pp. 621-627
-
-
Welters, C.F.1
Heineman, E.2
Thunnissen, F.B.3
Van Den Bogaard, A.E.4
Soeters, P.B.5
Baeten, C.G.6
-
106
-
-
12344249654
-
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial
-
Furrie, E.; Macfarlane, S.; Kennedy, A.; Cummings, J.H.; Walsh, S.V.; O’neil, D.A.; Macfarlane, G.T. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 2005, 54, 242–249.
-
(2005)
Gut
, vol.54
, pp. 242-249
-
-
Furrie, E.1
Macfarlane, S.2
Kennedy, A.3
Cummings, J.H.4
Walsh, S.V.5
O’Neil, D.A.6
Macfarlane, G.T.7
-
107
-
-
63049108842
-
A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis
-
Fujimori, S.; Gudis, K.; Mitsui, K.; Seo, T.; Yonezawa, M.; Tanaka, S.; Tatsuguchi, A.; Sakamoto, C. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 2009, 25, 520–525.
-
(2009)
Nutrition
, vol.25
, pp. 520-525
-
-
Fujimori, S.1
Gudis, K.2
Mitsui, K.3
Seo, T.4
Yonezawa, M.5
Tanaka, S.6
Tatsuguchi, A.7
Sakamoto, C.8
-
108
-
-
79955109038
-
Otani, T. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: A randomized controlled study
-
Ishikawa, H.; Matsumoto, S.; Ohashi, Y.; Imaoka, A.; Setoyama, H.; Umesaki, Y.; Tanaka, R.; Otani, T. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: A randomized controlled study. Digestion 2011, 84, 128–133.
-
(2011)
Digestion
, vol.84
, pp. 128-133
-
-
Ishikawa, H.1
Matsumoto, S.2
Ohashi, Y.3
Imaoka, A.4
Setoyama, H.5
Umesaki, Y.6
Tanaka, R.7
-
109
-
-
2442453484
-
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics
-
Sartor, R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126, 1620–1633.
-
(2004)
Gastroenterology
, vol.126
, pp. 1620-1633
-
-
Sartor, R.B.1
-
110
-
-
84873625596
-
Use of antibiotics in the treatment of Crohn’s disease. World
-
Scribano, M.L.; Prantera, C. Use of antibiotics in the treatment of Crohn’s disease. World J. Gastroenterol. 2013, 19, 648–653.
-
(2013)
J. Gastroenterol
, vol.19
, pp. 648-653
-
-
Scribano, M.L.1
Prantera, C.2
-
111
-
-
84890069587
-
Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients
-
Thorkildsen, L.T.; Nwosu, F.C.; Avershina, E.; Ricanek, P.; Perminow, G.; Brackmann, S.; Vatn, M.H.; Rudi, K. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. Gastroenterol. Res. Pract. 2013, 2013, 636785.
-
(2013)
Gastroenterol. Res. Pract
, vol.2013
-
-
Thorkildsen, L.T.1
Nwosu, F.C.2
Avershina, E.3
Ricanek, P.4
Perminow, G.5
Brackmann, S.6
Vatn, M.H.7
Rudi, K.8
-
112
-
-
84907960361
-
Gut microbiota and inflammatory bowel disease: The role of antibiotics in disease management
-
Kerman, D.H.; Deshpande, A.R. Gut microbiota and inflammatory bowel disease: The role of antibiotics in disease management. Postgrad. Med. 2014, 126, 7–19.
-
(2014)
Postgrad. Med
, vol.126
, pp. 7-19
-
-
Kerman, D.H.1
Deshpande, A.R.2
-
113
-
-
56849106496
-
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing
-
Dethlefsen, L.; Huse, S.; Sogin, M.L.; Relman, D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6, e280.
-
(2008)
Plos Biol
, vol.6
-
-
Dethlefsen, L.1
Huse, S.2
Sogin, M.L.3
Relman, D.A.4
-
114
-
-
84929892612
-
Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
-
Berg, D.; Clemente, J.C.; Colombel, J.F. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? Expert Rev. Gastroenterol. Hepatol. 2015, 9, 781–795.
-
(2015)
Expert Rev. Gastroenterol. Hepatol
, vol.9
, pp. 781-795
-
-
Berg, D.1
Clemente, J.C.2
Colombel, J.F.3
-
115
-
-
37449017195
-
Bacterial biofilm suppression with antibiotics for ulcerative and indeterminate colitis: Consequences of aggressive treatment
-
Swidsinski, A.; Loening-Baucke, V.; Bengmark, S.; Scholze, J.; Doerffel, Y. Bacterial biofilm suppression with antibiotics for ulcerative and indeterminate colitis: Consequences of aggressive treatment. Arch. Med. Res. 2008, 39, 198–204.
-
(2008)
Arch. Med. Res.
, vol.39
, pp. 198-204
-
-
Swidsinski, A.1
Loening-Baucke, V.2
Bengmark, S.3
Scholze, J.4
Doerffel, Y.5
-
116
-
-
78149477874
-
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: An in vitro approach using a continuous culture colonic model system
-
Maccaferri, S.; Vitali, B.; Klinder, A.; Kolida, S.; Ndagijimana, M.; Laghi, L.; Calanni, F.; Brigidi, P.; Gibson, G.R.; Costabile, A. Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: An in vitro approach using a continuous culture colonic model system. J. Antimicrob. Chemother. 2010, 65, 2556–2565.
-
(2010)
J. Antimicrob. Chemother
, vol.65
, pp. 2556-2565
-
-
Maccaferri, S.1
Vitali, B.2
Klinder, A.3
Kolida, S.4
Ndagijimana, M.5
Laghi, L.6
Calanni, F.7
Brigidi, P.8
Gibson, G.R.9
Costabile, A.10
-
117
-
-
0017879079
-
Metronidazole in Crohn’s disease. A double blind cross-over clinical trial. Scand
-
Blichfeldt, P.; Blomhoff, J.P.; Myhre, E.; Gjone, E. Metronidazole in Crohn’s disease. A double blind cross-over clinical trial. Scand. J. Gastroenterol. 1978, 13, 123–127.
-
(1978)
J. Gastroenterol
, vol.13
, pp. 123-127
-
-
Blichfeldt, P.1
Blomhoff, J.P.2
Myhre, E.3
Gjone, E.4
-
118
-
-
0019971845
-
A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: The cooperative Crohn’s disease study in Sweden. II. Result
-
Ursing, B.; Alm, T.; Barany, F.; Bergelin, I.; Ganrot-Norlin, K.; Hoevels, J.; Huitfeldt, B.; Jarnerot, G.; Krause, U.; Krook, A. et al. A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: The cooperative Crohn’s disease study in Sweden. II. Result. Gastroenterology 1982, 83, 550–562.
-
(1982)
Gastroenterology
, vol.83
, pp. 550-562
-
-
Ursing, B.1
Alm, T.2
Barany, F.3
Bergelin, I.4
Ganrot-Norlin, K.5
Hoevels, J.6
Huitfeldt, B.7
Jarnerot, G.8
Krause, U.9
Krook, A.10
-
119
-
-
0025887808
-
Double blind, placebo controlled trial of metronidazole in Crohn’s disease
-
Sutherland, L.; Singleton, J.; Sessions, J.; Hanauer, S.; Krawitt, E.; Rankin, G.; Summers, R.; Mekhjian, H.; Greenberger, N.; Kelly, M. et al. Double blind, placebo controlled trial of metronidazole in Crohn’s disease. Gut 1991, 32, 1071–1075.
-
(1991)
Gut
, vol.32
, pp. 1071-1075
-
-
Sutherland, L.1
Singleton, J.2
Sessions, J.3
Hanauer, S.4
Krawitt, E.5
Rankin, G.6
Summers, R.7
Mekhjian, H.8
Greenberger, N.9
Kelly, M.10
-
120
-
-
61949132271
-
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: A randomized, double-blind, placebo-controlled pilot study. Inflamm
-
Thia, K.T.; Mahadevan, U.; Feagan, B.G.; Wong, C.; Cockeram, A.; Bitton, A.; Bernstein, C.N.; Sandborn, W.J. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: A randomized, double-blind, placebo-controlled pilot study. Inflamm. Bowel Dis. 2009, 15, 17–24.
-
(2009)
Bowel Dis
, vol.15
, pp. 17-24
-
-
Thia, K.T.1
Mahadevan, U.2
Feagan, B.G.3
Wong, C.4
Cockeram, A.5
Bitton, A.6
Bernstein, C.N.7
Sandborn, W.J.8
-
121
-
-
84969418718
-
Meta-analysis of ciprofloxacin in treatment of Crohn’s disease
-
Wu, X.W.; Ji, H.Z.; Wang, F.Y. Meta-analysis of ciprofloxacin in treatment of Crohn’s disease. Biomed. Rep. 2015, 3, 70–74.
-
(2015)
Biomed. Rep.
, vol.3
, pp. 70-74
-
-
Wu, X.W.1
Ji, H.Z.2
Wang, F.Y.3
-
122
-
-
33646884826
-
Antibiotic treatment of Crohn’s disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
-
Prantera, C.; Lochs, H.; Campieri, M.; Scribano, M.L.; Sturniolo, G.C.; Castiglione, F.; Cottone, M. Antibiotic treatment of Crohn’s disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment. Pharmacol. Ther. 2006, 23, 1117–1125.
-
(2006)
Aliment. Pharmacol. Ther
, vol.23
, pp. 1117-1125
-
-
Prantera, C.1
Lochs, H.2
Campieri, M.3
Scribano, M.L.4
Sturniolo, G.C.5
Castiglione, F.6
Cottone, M.7
-
123
-
-
0347694843
-
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease
-
Castiglione, F.; Rispo, A.; Di, G.E.; Cozzolino, A.; Manguso, F.; Grassia, R.; Mazzacca, G. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease. Aliment. Pharmacol. Ther. 2003, 18, 1107–1112.
-
(2003)
Aliment. Pharmacol. Ther
, vol.18
, pp. 1107-1112
-
-
Castiglione, F.1
Rispo, A.2
Di, G.E.3
Cozzolino, A.4
Manguso, F.5
Grassia, R.6
Mazzacca, G.7
-
124
-
-
0022392051
-
Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis
-
Dickinson, R.J.; O’Connor, H.J.; Pinder, I.; Hamilton, I.; Johnston, D.; Axon, A.T. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985, 26, 1380–1384.
-
(1985)
Gut
, vol.26
, pp. 1380-1384
-
-
Dickinson, R.J.1
O’Connor, H.J.2
Pinder, I.3
Hamilton, I.4
Johnston, D.5
Axon, A.T.6
-
125
-
-
0022505628
-
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis
-
Chapman, R.W.; Selby, W.S.; Jewell, D.P. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986, 27, 1210–1212.
-
(1986)
Gut
, vol.27
, pp. 1210-1212
-
-
Chapman, R.W.1
Selby, W.S.2
Jewell, D.P.3
-
126
-
-
0033059934
-
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial
-
Gionchetti, P.; Rizzello, F.; Ferrieri, A.; Venturi, A.; Brignola, C.; Ferretti, M.; Peruzzo, S.; Miglioli, M.; Campieri, M. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial. Dig. Dis. Sci. 1999, 44, 1220–1221.
-
(1999)
Dig. Dis. Sci.
, vol.44
, pp. 1220-1221
-
-
Gionchetti, P.1
Rizzello, F.2
Ferrieri, A.3
Venturi, A.4
Brignola, C.5
Ferretti, M.6
Peruzzo, S.7
Miglioli, M.8
Campieri, M.9
-
127
-
-
0031763109
-
Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study
-
Turunen, U.M.; Farkkila, M.A.; Hakala, K.; Seppala, K.; Sivonen, A.; Ogren, M.; Vuoristo, M.; Valtonen, V.V.; Miettinen, T.A. Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study. Gastroenterology 1998, 115, 1072–1078.
-
(1998)
Gastroenterology
, vol.115
, pp. 1072-1078
-
-
Turunen, U.M.1
Farkkila, M.A.2
Hakala, K.3
Seppala, K.4
Sivonen, A.5
Ogren, M.6
Vuoristo, M.7
Valtonen, V.V.8
Miettinen, T.A.9
-
128
-
-
84927797177
-
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report
-
Turner, D.; Levine, A.; Kolho, K.L.; Shaoul, R.; Ledder, O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report. J. Crohns Colitis 2014, 8, 1464–1470.
-
(2014)
J. Crohns Colitis
, vol.8
, pp. 1464-1470
-
-
Turner, D.1
Levine, A.2
Kolho, K.L.3
Shaoul, R.4
Ledder, O.5
-
129
-
-
33751229883
-
Antibiotic therapy for Crohn’s disease: A review
-
Lal, S.; Steinhart, A.H. Antibiotic therapy for Crohn’s disease: A review. Can. J. Gastroenterol. 2006, 20, 651–655.
-
(2006)
Can. J. Gastroenterol
, vol.20
, pp. 651-655
-
-
Lal, S.1
Steinhart, A.H.2
-
130
-
-
84941774045
-
The intestinal microbiota in inflammatory bowel disease
-
Becker, C.; Neurath, M.F.; Wirtz, S. The intestinal microbiota in inflammatory bowel disease. ILAR J. 2015, 56, 192–204.
-
(2015)
ILAR J.
, vol.56
, pp. 192-204
-
-
Becker, C.1
Neurath, M.F.2
Wirtz, S.3
-
131
-
-
84941774442
-
Intestinal Microbiota in Animal Models of Inflammatory Diseases
-
Hormannsperger, G.; Schaubeck, M.; Haller, D. Intestinal Microbiota in Animal Models of Inflammatory Diseases. ILAR J. 2015, 56, 179–191.
-
(2015)
ILAR J
, vol.56
, pp. 179-191
-
-
Hormannsperger, G.1
Schaubeck, M.2
Haller, D.3
-
132
-
-
77955961892
-
Durable alteration of the colonic microbiota by the administration of donor fecal flora
-
Grehan, M.J.; Borody, T.J.; Leis, S.M.; Campbell, J.; Mitchell, H.; Wettstein, A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J. Clin. Gastroenterol. 2010, 44, 551–561.
-
(2010)
J. Clin. Gastroenterol.
, vol.44
, pp. 551-561
-
-
Grehan, M.J.1
Borody, T.J.2
Leis, S.M.3
Campbell, J.4
Mitchell, H.5
Wettstein, A.6
-
133
-
-
84868254408
-
Fecal microbiota transplantation in relapsing Clostridium difficile infection
-
Rohlke, F.; Stollman, N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Ther. Adv. Gastroenterol. 2012, 5, 403–420.
-
(2012)
Ther. Adv. Gastroenterol
, vol.5
, pp. 403-420
-
-
Rohlke, F.1
Stollman, N.2
-
134
-
-
84887534716
-
Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease
-
Zhang, F.M.; Wang, H.G.; Wang, M.; Cui, B.T.; Fan, Z.N.; Ji, G.Z. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J. Gastroenterol. 2013, 19, 7213–7216.
-
(2013)
World J. Gastroenterol
, vol.19
, pp. 7213-7216
-
-
Zhang, F.M.1
Wang, H.G.2
Wang, M.3
Cui, B.T.4
Fan, Z.N.5
Ji, G.Z.6
-
136
-
-
0001412472
-
Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis
-
Eiseman, B.; Silen, W.; Bascom, G.S.; Kauvar, A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958, 44, 854–859.
-
(1958)
Surgery
, vol.44
, pp. 854-859
-
-
Eiseman, B.1
Silen, W.2
Bascom, G.S.3
Kauvar, A.J.4
-
137
-
-
0019454759
-
Pseudomembraneous enterocolitis: Mechanism for restoring floral homeostasis
-
Bowden, T.A., Jr.; Mansberger, A.R., Jr.; Lykins, L.E. Pseudomembraneous enterocolitis: Mechanism for restoring floral homeostasis. Am. Surg. 1981, 47, 178–183.
-
(1981)
Am. Surg
, vol.47
, pp. 178-183
-
-
Bowden, T.A.1
Mansberger, A.R.2
Lykins, L.E.3
-
138
-
-
15544372997
-
Alternative treatments for Clostridium difficile disease: What really works?
-
McFarland, L.V. Alternative treatments for Clostridium difficile disease: What really works? J. Med. Microbiol. 2005, 54, 101–111.
-
(2005)
J. Med. Microbiol
, vol.54
, pp. 101-111
-
-
McFarland, L.V.1
-
139
-
-
0021097993
-
Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces
-
Schwan, A.; Sjolin, S.; Trottestam, U.; Aronsson, B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983, 2
-
(1983)
Lancet
, vol.2
-
-
Schwan, A.1
Sjolin, S.2
Trottestam, U.3
Aronsson, B.4
-
140
-
-
77951700268
-
Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea
-
Khoruts, A.; Dicksved, J.; Jansson, J.K.; Sadowsky, M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44, 354–360.
-
(2010)
J. Clin. Gastroenterol
, vol.44
, pp. 354-360
-
-
Khoruts, A.1
Dicksved, J.2
Jansson, J.K.3
Sadowsky, M.J.4
-
141
-
-
80054736926
-
Systematic review of intestinal microbiota transplantation (Fecal bacteriotherapy) for recurrent Clostridium difficile infection
-
Gough, E.; Shaikh, H.; Manges, A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 2011, 53, 994–1002.
-
(2011)
Clin. Infect. Dis
, vol.53
, pp. 994-1002
-
-
Gough, E.1
Shaikh, H.2
Manges, A.R.3
-
142
-
-
84873019302
-
Duodenal infusion of donor feces for recurrent Clostridium difficile
-
Van Nood, E.; Vrieze, A.; Nieuwdorp, M.; Fuentes, S.; Zoetendal, E.G.; de Vos, W.M.; Visser, C.E.; Kuijper, E.J.; Bartelsman, J.F.; Tijssen, J.G. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368, 407–415.
-
(2013)
N. Engl. J. Med
, vol.368
, pp. 407-415
-
-
Van Nood, E.1
Vrieze, A.2
Nieuwdorp, M.3
Fuentes, S.4
Zoetendal, E.G.5
De Vos, W.M.6
Visser, C.E.7
Kuijper, E.J.8
Bartelsman, J.F.9
Tijssen, J.G.10
-
143
-
-
84875952150
-
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
-
Surawicz, C.M.; Brandt, L.J.; Binion, D.G.; Ananthakrishnan, A.N.; Curry, S.R.; Gilligan, P.H.; McFarland, L.V.; Mellow, M.; Zuckerbraun, B.S. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 2013, 108, 478–498.
-
(2013)
Am. J. Gastroenterol.
, vol.108
, pp. 478-498
-
-
Surawicz, C.M.1
Brandt, L.J.2
Binion, D.G.3
Ananthakrishnan, A.N.4
Curry, S.R.5
Gilligan, P.H.6
McFarland, L.V.7
Mellow, M.8
Zuckerbraun, B.S.9
-
144
-
-
84887259304
-
European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection
-
Debast, S.B.; Bauer, M.P.; Kuijper, E.J. European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20, 1–26.
-
(2014)
Clin. Microbiol. Infect
, vol.20
, pp. 1-26
-
-
Debast, S.B.1
Bauer, M.P.2
Kuijper, E.J.3
-
145
-
-
0024498413
-
Treatment of ulcerative colitis by implantation of normal colonic flora
-
Bennet, J.D.; Brinkman, M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989, 1
-
(1989)
Lancet
, vol.1
-
-
Bennet, J.D.1
Brinkman, M.2
-
146
-
-
0024970366
-
Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?
-
Borody, T.J.; George, L.; Andrews, P.; Brandl, S.; Noonan, S.; Cole, P.; Hyland, L.; Morgan, A.; Maysey, J.; Moore-Jones, D. Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Med. J. Aust. 1989, 150, 604
-
(1989)
Med. J. Aust
, vol.150
-
-
Borody, T.J.1
George, L.2
Andrews, P.3
Brandl, S.4
Noonan, S.5
Cole, P.6
Hyland, L.7
Morgan, A.8
Maysey, J.9
Moore-Jones, D.10
-
147
-
-
0038613653
-
Treatment of ulcerative colitis using fecal bacteriotherapy
-
Borody, T.J.; Warren, E.F.; Leis, S.; Surace, R.; Ashman, O. Treatment of ulcerative colitis using fecal bacteriotherapy. J. Clin. Gastroenterol. 2003, 37, 42–47.
-
(2003)
J. Clin. Gastroenterol
, vol.37
, pp. 42-47
-
-
Borody, T.J.1
Warren, E.F.2
Leis, S.3
Surace, R.4
Ashman, O.5
-
148
-
-
84918584474
-
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
-
Colman, R.J.; Rubin, D.T. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. J. Crohns Colitis 2014, 8, 1569–1581.
-
(2014)
J. Crohns Colitis
, vol.8
, pp. 1569-1581
-
-
Colman, R.J.1
Rubin, D.T.2
-
149
-
-
84880601378
-
Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol
-
De Leon, L.M.; Watson, J.B.; Kelly, C.R. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 2013, 11, 1036–1038.
-
(2013)
Hepatol
, vol.11
, pp. 1036-1038
-
-
De Leon, L.M.1
Watson, J.B.2
Kelly, C.R.3
-
150
-
-
84903894091
-
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients
-
Kelly, C.R.; Ihunnah, C.; Fischer, M.; Khoruts, A.; Surawicz, C.; Afzali, A.; Aroniadis, O.; Barto, A.; Borody, T.; Giovanelli, A. et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am. J. Gastroenterol. 2014, 109, 1065–1071.
-
(2014)
Am. J. Gastroenterol
, vol.109
, pp. 1065-1071
-
-
Kelly, C.R.1
Ihunnah, C.2
Fischer, M.3
Khoruts, A.4
Surawicz, C.5
Afzali, A.6
Aroniadis, O.7
Barto, A.8
Borody, T.9
Giovanelli, A.10
-
151
-
-
84931469899
-
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
-
Moayyedi, P.; Surette, M.G.; Kim, P.T.; Libertucci, J.; Wolfe, M.; Onischi, C.; Armstrong, D.; Marshall, J.K.; Kassam, Z.; Reinisch, W. et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015, 149, 102–109.
-
(2015)
Gastroenterology
, vol.149
, pp. 102-109
-
-
Moayyedi, P.1
Surette, M.G.2
Kim, P.T.3
Libertucci, J.4
Wolfe, M.5
Onischi, C.6
Armstrong, D.7
Marshall, J.K.8
Kassam, Z.9
Reinisch, W.10
-
152
-
-
84931423571
-
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
-
Rossen, N.G.; Fuentes, S.; van der Spek, M.J.; Tijssen, J.G.; Hartman, J.H.; Duflou, A.; Lowenberg, M.; van den Brink, G.R.; Mathus-Vliegen, E.M.; de Vos, W.M. et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology 2015, 149, 110–118.
-
(2015)
Gastroenterology
, vol.149
, pp. 110-118
-
-
Rossen, N.G.1
Fuentes, S.2
Van Der Spek, M.J.3
Tijssen, J.G.4
Hartman, J.H.5
Duflou, A.6
Lowenberg, M.7
Van Den Brink, G.R.8
Mathus-Vliegen, E.M.9
De Vos, W.M.10
-
153
-
-
84868158515
-
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice
-
Lawley, T.D.; Clare, S.; Walker, A.W.; Stares, M.D.; Connor, T.R.; Raisen, C.; Goulding, D.; Rad, R.; Schreiber, F.; Brandt, C. et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012, 8, e1002995.
-
(2012)
Plos Pathog
, vol.8
-
-
Lawley, T.D.1
Clare, S.2
Walker, A.W.3
Stares, M.D.4
Connor, T.R.5
Raisen, C.6
Goulding, D.7
Rad, R.8
Schreiber, F.9
Brandt, C.10
-
154
-
-
84877020842
-
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut
-
Petrof, E.O.; Gloor, G.B.; Vanner, S.J.; Weese, S.J.; Carter, D.; Daigneault, M.C.; Brown, E.M.; Schroeter, K.; Allen-Vercoe, E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome 2013, 1.
-
(2013)
Microbiome
-
-
Petrof, E.O.1
Gloor, G.B.2
Vanner, S.J.3
Weese, S.J.4
Carter, D.5
Daigneault, M.C.6
Brown, E.M.7
Schroeter, K.8
Allen-Vercoe, E.9
-
155
-
-
84932146365
-
Freeze-dried, capsulized fecal microbiota transplantation for relapsing Clostridium difficile infection
-
Tian, H.; Ding, C.; Gong, J.; Wei, Y.; McFarland, L.V.; Li, N. Freeze-dried, capsulized fecal microbiota transplantation for relapsing Clostridium difficile infection. J. Clin. Gastroenterol. 2015, 49, 537–538.
-
(2015)
J. Clin. Gastroenterol
, vol.49
, pp. 537-538
-
-
Tian, H.1
Ding, C.2
Gong, J.3
Wei, Y.4
McFarland, L.V.5
Li, N.6
-
156
-
-
84908681868
-
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection
-
Youngster, I.; Russell, G.H.; Pindar, C.; Ziv-Baran, T.; Sauk, J.; Hohmann, E.L. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014, 312, 1772–1778.
-
(2014)
JAMA
, vol.312
, pp. 1772-1778
-
-
Youngster, I.1
Russell, G.H.2
Pindar, C.3
Ziv-Baran, T.4
Sauk, J.5
Hohmann, E.L.6
-
157
-
-
84919983202
-
The emering role of helminths in treatment of the inflammatory bowel disorders
-
Szkudlapski, D.; Labuzek, K.; Pokora, Z.; Smyla, N.; Gonciarz, M.; Mularczyk, A.; Maluch, P.; Okopien, B. The emering role of helminths in treatment of the inflammatory bowel disorders. J. Physiol. Pharmacol. 2014, 65, 741–751.
-
(2014)
J. Physiol. Pharmacol
, vol.65
, pp. 741-751
-
-
Szkudlapski, D.1
Labuzek, K.2
Pokora, Z.3
Smyla, N.4
Gonciarz, M.5
Mularczyk, A.6
Maluch, P.7
Okopien, B.8
-
158
-
-
84927520409
-
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: Origins, pathophysiology, and clinical applications
-
Versini, M.; Jeandel, P.Y.; Bashi, T.; Bizzaro, G.; Blank, M.; Shoenfeld, Y. Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: Origins, pathophysiology, and clinical applications. BMC Med. 2015, 13, 81.
-
(2015)
BMC Med
, vol.13
-
-
Versini, M.1
Jeandel, P.Y.2
Bashi, T.3
Bizzaro, G.4
Blank, M.5
Shoenfeld, Y.6
-
159
-
-
33748581045
-
Parasitic worms and inflammatory diseases
-
Zaccone, P.; Fehervari, Z.; Phillips, J.M.; Dunne, D.W.; Cooke, A. Parasitic worms and inflammatory diseases. Parasite Immunol. 2006, 28, 515–523.
-
(2006)
Parasite Immunol
, vol.28
, pp. 515-523
-
-
Zaccone, P.1
Fehervari, Z.2
Phillips, J.M.3
Dunne, D.W.4
Cooke, A.5
-
160
-
-
84944165332
-
Do we need worms to promote immune health?
-
Weinstock, J.V. Do we need worms to promote immune health? Clin. Rev. Allergy Immunol. 2015, 49, 227–231.
-
(2015)
Clin. Rev. Allergy Immunol
, vol.49
, pp. 227-231
-
-
Weinstock, J.V.1
-
161
-
-
84908213699
-
Treating inflammatory bowel disease: From helminths to ova
-
Bashi, T.; Blank, M.; Shoenfeld, Y. Treating inflammatory bowel disease: From helminths to ova. Isr. Med. Assoc. J. 2014, 16, 627–628.
-
(2014)
Isr. Med. Assoc. J
, vol.16
, pp. 627-628
-
-
Bashi, T.1
Blank, M.2
Shoenfeld, Y.3
-
162
-
-
84873733555
-
Translatability of helminth therapy in inflammatory bowel diseases
-
Weinstock, J.V.; Elliott, D.E. Translatability of helminth therapy in inflammatory bowel diseases. Int. J. Parasitol. 2013, 43, 245–251.
-
(2013)
Int. J. Parasitol
, vol.43
, pp. 245-251
-
-
Weinstock, J.V.1
Elliott, D.E.2
-
163
-
-
84936984348
-
Suppression of inflammation by helminths: A role for the gut microbiota? Philos
-
Giacomin, P.; Croese, J.; Krause, L.; Loukas, A.; Cantacessi, C. Suppression of inflammation by helminths: A role for the gut microbiota? Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015
-
(2015)
Trans. R. Soc. Lond. B Biol. Sci
-
-
Giacomin, P.1
Croese, J.2
Krause, L.3
Loukas, A.4
Cantacessi, C.5
-
164
-
-
84873732487
-
The hookworm pharmacopoeia for inflammatory diseases
-
Navarro, S.; Ferreira, I.; Loukas, A. The hookworm pharmacopoeia for inflammatory diseases. Int. J. Parasitol. 2013, 43, 225–231.
-
(2013)
Int. J. Parasitol
, vol.43
, pp. 225-231
-
-
Navarro, S.1
Ferreira, I.2
Loukas, A.3
-
165
-
-
84908337264
-
Helminth therapy or elimination: Epidemiological, immunological, and clinical considerations
-
Wammes, L.J.; Mpairwe, H.; Elliott, A.M.; Yazdanbakhsh, M. Helminth therapy or elimination: Epidemiological, immunological, and clinical considerations. Lancet Infect. Dis. 2014, 14, 1150–1162.
-
(2014)
Lancet Infect. Dis
, vol.14
, pp. 1150-1162
-
-
Wammes, L.J.1
Mpairwe, H.2
Elliott, A.M.3
Yazdanbakhsh, M.4
-
166
-
-
84926420585
-
The microbiota and helminths: Sharing the same niche in the human host
-
Glendinning, L.; Nausch, N.; Free, A.; Taylor, D.W.; Mutapi, F. The microbiota and helminths: Sharing the same niche in the human host. Parasitology 2014, 141, 1255–1271.
-
(2014)
Parasitology
, vol.141
, pp. 1255-1271
-
-
Glendinning, L.1
Nausch, N.2
Free, A.3
Taylor, D.W.4
Mutapi, F.5
-
167
-
-
84903542295
-
Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction
-
Foth, B.J.; Tsai, I.J.; Reid, A.J.; Bancroft, A.J.; Nichol, S.; Tracey, A.; Holroyd, N.; Cotton, J.A.; Stanley, E.J.; Zarowiecki, M. et al. Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction. Nat. Genet. 2014, 46, 693–700.
-
(2014)
Nat. Genet
, vol.46
, pp. 693-700
-
-
Foth, B.J.1
Tsai, I.J.2
Reid, A.J.3
Bancroft, A.J.4
Nichol, S.5
Tracey, A.6
Holroyd, N.7
Cotton, J.A.8
Stanley, E.J.9
Zarowiecki, M.10
-
168
-
-
0017229523
-
The relationship between Trichuris trichiura (Linnaeus 1758) of man and Trichuris suis (Schrank 1788) of the pig
-
Beer, R.J. The relationship between Trichuris trichiura (Linnaeus 1758) of man and Trichuris suis (Schrank 1788) of the pig. Res. Vet. Sci. 1976, 20, 47–54.
-
(1976)
Res. Vet. Sci
, vol.20
, pp. 47-54
-
-
Beer, R.J.1
-
169
-
-
84925455456
-
Human helminth therapy to treat inflammatory disorders—Where do we stand?
-
Helmby, H. Human helminth therapy to treat inflammatory disorders—Where do we stand? BMC Immunol. 2015, 16, 12.
-
(2015)
BMC Immunol
, vol.16
-
-
Helmby, H.1
-
170
-
-
0141459691
-
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease
-
Summers, R.W.; Elliott, D.E.; Qadir, K.; Urban, J.F., Jr.; Thompson, R.; Weinstock, J.V. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 2003, 98, 2034–2041.
-
(2003)
Am. J. Gastroenterol
, vol.98
, pp. 2034-2041
-
-
Summers, R.W.1
Elliott, D.E.2
Qadir, K.3
Urban, J.F.4
Thompson, R.5
Weinstock, J.V.6
-
171
-
-
10844224526
-
Trichuris suis therapy in Crohn’s disease
-
Summers, R.W.; Elliott, D.E.; Urban, J.F., Jr.; Thompson, R.; Weinstock, J.V. Trichuris suis therapy in Crohn’s disease. Gut 2005, 54, 87–90.
-
(2005)
Gut
, vol.54
, pp. 87-90
-
-
Summers, R.W.1
Elliott, D.E.2
Urban, J.F.3
Thompson, R.4
Weinstock, J.V.5
-
172
-
-
17144402166
-
Trichuris suis therapy for active ulcerative colitis
-
Summers, R.W.; Elliott, D.E.; Urban, J.F., Jr.; Thompson, R.A.; Weinstock, J.V. Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 2005, 128, 825–832.
-
(2005)
A Randomized Controlled Trial. Gastroenterology
, vol.128
, pp. 825-832
-
-
Summers, R.W.1
Elliott, D.E.2
Urban, J.F.3
Thompson, R.A.4
Weinstock, J.V.5
-
173
-
-
84879780748
-
Randomised clinical trial: The safety and tolerability of Trichuris suis ova in patients with Crohn's disease
-
Sandborn, W.J.; Elliott, D.E.; Weinstock, J.; Summers, R.W.; Landry-Wheeler, A.; Silver, N.; Harnett, M.D.; Hanauer, S.B. Randomised clinical trial: The safety and tolerability of Trichuris suis ova in patients with Crohn's disease. Aliment. Pharmacol. Ther. 2013, 38, 255–263.
-
(2013)
Aliment. Pharmacol. Ther
, vol.38
, pp. 255-263
-
-
Sandborn, W.J.1
Elliott, D.E.2
Weinstock, J.3
Summers, R.W.4
Landry-Wheeler, A.5
Silver, N.6
Harnett, M.D.7
Hanauer, S.B.8
-
174
-
-
84895883455
-
Genome of the human hookworm Necator americanus
-
Tang, Y.T.; Gao, X.; Rosa, B.A.; Abubucker, S.; Hallsworth-Pepin, K.; Martin, J.; Tyagi, R.; Heizer, E.; Zhang, X.; Bhonagiri-Palsikar, V. et al. Genome of the human hookworm Necator americanus. Nat. Genet. 2014, 46, 261–269.
-
(2014)
Nat. Genet
, vol.46
, pp. 261-269
-
-
Tang, Y.T.1
Gao, X.2
Rosa, B.A.3
Abubucker, S.4
Hallsworth-Pepin, K.5
Martin, J.6
Tyagi, R.7
Heizer, E.8
Zhang, X.9
Bhonagiri-Palsikar, V.10
-
175
-
-
4143058228
-
Hookworm infection
-
Hotez, P.J.; Brooker, S.; Bethony, J.M.; Bottazzi, M.E.; Loukas, A.; Xiao, S. Hookworm infection. N. Engl. J. Med. 2004, 351, 799–807.
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 799-807
-
-
Hotez, P.J.1
Brooker, S.2
Bethony, J.M.3
Bottazzi, M.E.4
Loukas, A.5
Xiao, S.6
-
176
-
-
29244453651
-
A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors
-
Croese, J.; O’neil, J.; Masson, J.; Cooke, S.; Melrose, W.; Pritchard, D.; Speare, R. A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors. Gut 2006, 55, 136–137.
-
(2006)
Gut
, vol.55
, pp. 136-137
-
-
Croese, J.1
O’Neil, J.2
Masson, J.3
Cooke, S.4
Melrose, W.5
Pritchard, D.6
Speare, R.7
-
177
-
-
84922341089
-
Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease
-
Croese, J.; Giacomin, P.; Navarro, S.; Clouston, A.; McCann, L.; Dougall, A.; Ferreira, I.; Susianto, A.; O'Rourke, P.; Howlett, M. et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J. Allergy Clin. Immunol. 2015, 135, 508–516.
-
(2015)
J. Allergy Clin. Immunol
, vol.135
, pp. 508-516
-
-
Croese, J.1
Giacomin, P.2
Navarro, S.3
Clouston, A.4
McCann, L.5
Dougall, A.6
Ferreira, I.7
Susianto, A.8
O'rourke, P.9
Howlett, M.10
-
178
-
-
84860276395
-
Characterising the mucosal and systemic immune responses to experimental human hookworm infection
-
Gaze, S.; McSorley, H.J.; Daveson, J.; Jones, D.; Bethony, J.M.; Oliveira, L.M.; Speare, R.; McCarthy, J.S.; Engwerda, C.R.; Croese, J. et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog. 2012, 8, e1002520.
-
(2012)
Plos Pathog
, vol.8
-
-
Gaze, S.1
McSorley, H.J.2
Daveson, J.3
Jones, D.4
Bethony, J.M.5
Oliveira, L.M.6
Speare, R.7
McCarthy, J.S.8
Engwerda, C.R.9
Croese, J.10
-
179
-
-
84901808283
-
Helminth colonization is associated with increased diversity of the gut microbiota
-
Lee, S.C.; Tang, M.S.; Lim, Y.A.; Choy, S.H.; Kurtz, Z.D.; Cox, L.M.; Gundra, U.M.; Cho, I.; Bonneau, R.; Blaser, M.J. et al. Helminth colonization is associated with increased diversity of the gut microbiota. PLoS Negl. Trop. Dis. 2014, 8, e2880.
-
(2014)
Plos Negl. Trop. Dis
, vol.8
-
-
Lee, S.C.1
Tang, M.S.2
Lim, Y.A.3
Choy, S.H.4
Kurtz, Z.D.5
Cox, L.M.6
Gundra, U.M.7
Cho, I.8
Bonneau, R.9
Blaser, M.J.10
-
180
-
-
34250375140
-
Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease
-
Sepehri, S.; Kotlowski, R.; Bernstein, C.N.; Krause, D.O. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13, 675–683.
-
(2007)
Inflamm. Bowel Dis
, vol.13
, pp. 675-683
-
-
Sepehri, S.1
Kotlowski, R.2
Bernstein, C.N.3
Krause, D.O.4
-
181
-
-
84922032616
-
Impact of experimental hookworm infection on the human gut microbiota
-
Cantacessi, C.; Giacomin, P.; Croese, J.; Zakrzewski, M.; Sotillo, J.; McCann, L.; Nolan, M.J.; Mitreva, M.; Krause, L.; Loukas, A. Impact of experimental hookworm infection on the human gut microbiota. J. Infect. Dis. 2014, 210, 1431–1434.
-
(2014)
J. Infect. Dis
, vol.210
, pp. 1431-1434
-
-
Cantacessi, C.1
Giacomin, P.2
Croese, J.3
Zakrzewski, M.4
Sotillo, J.5
McCann, L.6
Nolan, M.J.7
Mitreva, M.8
Krause, L.9
Loukas, A.10
|